16th August 2021 Product update: rapidvirology staff writer
Rapid FDA-EUA Test for Both SARS-CoV-2 and Influenza Antigens
Becton, Dicksonson, and Company (BD) are now taking pre-orders for their BD Veritor™ SARS-CoV-2 and Flu A+B combo test. The test was granted Emergency Use Authorization by the US FDA in March 2021.
The BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B assay takes about 15 minutes to run on the BD Veritor™ Plus System and distinguishes between SARS-CoV-2, influenza A and influenza B, by providing definitive positive or negative individual digital display readouts for all three.
- Buy 2 SARS-CoV-2 and Flu A+B kits, get an analyzer at no additional cost
- Buy 4 SARS-CoV-2 and Flu A+B kits, get a 5th at no additional cost
The test is intended for individuals who are suspected by a health care provider of having COVID-19, influenza A or influenza B within six days of symptom onset. The test follows the same, simple workflow as other rapid tests on the BD Veritor™ Plus System.
Visit BD.com or make contact via the 'Request Information' button provided below.
Date Published: 16th August 2021
Source article link: View
Note: This content has been edited by a rapidvirology.com staff writer for style and content.
Industry-First CE-IVD Assay for HPV
FDA Authorize COVID-19 Self-Test for